New shingles vaccine could reduce risk of dementia

A study of more than 200,000 people by researchers at the University of Oxford found at least a 17% reduction in dementia diagnoses in the six years after the new recombinant shingles vaccination, equating to 164 or more additional days lived without dementia.

This post was originally published on this site

Lawyers Lookup - LawyersLookup.ca